China In Vitro Diagnostics Market

1
China IVD Market
Category Diagnostics Market Report
2
China IVD Market Analyst View China InVitro
Diagnostics (IVD) Market is projected to exceed
US 12 Billion by the end of year 2024. Get Free
Customization in this Report Research Report
Title China InVitro Diagnostics (IVD) Market,
By Diagnostics (Immunoassay, Microbiology,
Molecular, SMBG, POCT etc.) Companies Access
Full Research https//www.renub.com/china-in-vitr
o-diagnostics-ivd-market-forecast-companies-analys
is-registration-rules-1089-p.php  

3
China IVD Market is projected to exceed US 12
Billion by the end of year 2024.
China InVitro Diagnostics (IVD) Market is
projected to exceed US 12 Billion by the end of
year 2024. China IVD Market is growing
significantly and is expected to continue its
ongoing trend during the forecast period as well,
owing to rapidly increasing middle class
population who is now willing to pay more for
better healthcare services and aging population
who are more vulnerable to contagious diseases.
Also, Chinese aging population is experiencing an
outburst of chronic diseases which includes
cancer, diabetes and cardiovascular disease. All
of these diseases can be diagnosed and monitored
using IVD products. In addition some other
factors which can be attributed to China IVD
market include growing prevalence of chronic
lifestyle and infectious diseases, public health
awareness, transformation of medical models,
increasing demand of tests from the rural areas
and support from the Chinese government to
provide better healthcare infrastructure
throughout the nation.  Request a free sample
copy of the report https//www.renub.com/contactu
s.php

4
China IVD Market is projected to exceed US 12
Billion by the end of year 2024.
Renub Research report titled China InVitro
Diagnostics (IVD) Market, By Diagnostics
Clinical Chemistry, Immunoassay, Hematology,
Coagulation, Microbiology, Molecular Testing,
Self Monitoring of Blood Glucose (SMBG), Point of
Care Testing (POCT), Companies (Roche
Diagnostics, Sysmex Corporation, Mindray Medical
International Limited, Shanghai Kehua
Bio-Engineering Co. Ltd., Abbott Laboratories
Others) provides a complete analysis of China
InVitro Diagnostics (IVD) Market. By Segment
Immunoassay and Clinical Chemistry dominates the
China IVD Market The report studies the market of
the following InVitro Diagnostics (IVD)
segments Clinical Chemistry, Immunoassay,
Hematology, Coagulation, Microbiology, Molecular
Testing, Self Monitoring of Blood Glucose (SMBG),
and Point of Care Testing (POCT). Companies
Analysis Roche Diagnostics, Sysmex Corporation,
Mindray Medical International Limited, Shanghai
Kehua Bio-Engineering Co. Ltd., Abbott
Laboratories are some of the top companies
operating in the China IVD Market which has been
studied thoroughly in the report.

5
China IVD Market is projected to exceed US 12
Billion by the end of year 2024.

6
China IVD Market is projected to exceed US 12
Billion by the end of year 2024.
Companies Analysis Roche Diagnostics, Sysmex
Corporation, Mindray Medical International
Limited, Shanghai Kehua Bio-Engineering Co. Ltd.,
Abbott Laboratories are some of the top companies
operating in the China IVD Market which has been
studied thoroughly in the report. The report
China InVitro Diagnostics (IVD) Market has been
studied from 7 viewpoints  1)    Market
Forecast 2)    Segment Wise Market
Forecast 3)    Development Environment
Regulatory Status in China IVD market 4)  
 Company-wise IVD Sales Forecast5)    Profiles
of Private Clinical Labs and Diagnostic
Services6)    Growth Drivers for China In-Vitro
Diagnostics7)    Challenges for China In-Vitro
Diagnostics    Client can Purchase this Report in
Sections from below link Access full Research 
https//www.renub.com/china-in-vitro-diagnostics-i
vd-market-forecast-companies-analysis-registration
-rules-1089-p.php

7
China IVD Market is projected to exceed US 12
Billion by the end of year 2024.
This market research report provides a complete
analysis of the China In-Vitro Diagnostics (IVD)
Market, Growth Drivers, Challenges, and their
projections for the upcoming years.   By
Segment 1.    Clinical Chemistry 2.  
 Immunoassay 3.    Hematology  4.  
 Coagulation 5.    Microbiology  6.  
 Molecular Testing7.    Self Monitoring of Blood
Glucose 8.    Point of Care Testing
(POCT) Companies Covered in the Report 1.  
 Roche Diagnostics 2.    Sysmex
Corporation3.    Mindray Medical International
Limited 4.    Abbott Laboratories 5.  
 Shanghai Kehua Bio-Engineering Co. Ltd. 6.  
 Others Profiles of Private Clinical Labs and
Diagnostic Services Companies in China   
 Zhejiang Dian Diagnostics     ADICON
Clinical Laboratories    Guangzhou Kingmed
    Kindstar Global (Privately held)  
 BGI-Shenzhen (Privately held)     OriGene
Technologies (Privately held)

8
Table of Contents for China InVitro Diagnostics
Market
Key Topics Covered 1. Executive
Summary   2.    China IVD Market (2007
2024)   3.    Market Share China In Vitro
Diagnostics (IVD) (2011 2024) 3.1    Segments
China IVD 3.2    Companies China IVD   4.  
 Segments China IVD Market (2007 2024) 4.1  
 Clinical Chemistry Market 4.2    Immunoassay
Market4.3    Hematology Market 4.4  
 Coagulation Market4.5    Microbiology
Market 4.6    Molecular Diagnostic Market4.7  
 Self Monitoring of Blood Glucose (SMBG)
Market4.8    Point of Care Testing (POCT)
Market  

9
Table of Contents for China InVitro Diagnostics
Market
5.    Development Environment of Chinese IVD
Industry 5.1    Healthcare Reforms 5.2  
 Improving Quality at Grass-Root Level5.3  
 Embracing Technology 6.    China Health
Insurance and Reimbursement Policies 6.1  
 Health Insurance System 6.2    Reimbursement
Rules   7.    Registration of In Vitro Diagnostic
Reagents in China 7.1    Registration and
Filing7.2    Filing Obligation for Clinical
Trials7.3    Clinical Trial Institutions7.4  
 Elimination of IVD Loophole for Research7.5  
 Change of Manufacturing Address7.6    Change of
Main Supplier of an Antigen or Antibody7.7  
 Update on China In-Vitro Diagnostics
Registration  

10
Table of Contents for China InVitro Diagnostics
Market
8.    Medical Devices and Reagents Class
Registration in China 8.1    Process of Medical
Device Registration in China8.2  
 Classification of In-vitro Diagnostic Reagents
in China 8.3    China In-Vitro Diagnostics
Reagents 9.    China IVD Industry Drivers 9.1  
 Increasing Demand from Middle Class for High
Quality Healthcare Products9.2    Rising
Incidences of Lifestyle Diseases in China9.3  
 Growth in Private Hospitals Independent
Diagnostic Centers   10.    China IVD Industry
Challenges 10.1    Chinese Local Firms Lack of
Expertise in Advanced Technology10.2    Cost
Factor Restricts the Contribution of Global IVD
Companies in the Chinese IVD Market10.3  
 Reimbursement Rates varies from Province to
Province in China    

11
Table of Contents for China InVitro Diagnostics
Market
11.    Company Sales Analysis (2011
2024) 11.1    Roche Diagnostics - China IVD Sales
Forecast11.2    Sysmex Corporation - China IVD
Sales Forecast11.3    Mindray Medical
International Limited - China IVD Sales
Forecast11.4    Shanghai Kehua Bio-Engineering
Co. Ltd. - China IVD Sales Forecast11.5  
 Abbott Laboratories - China IVD Sales
Forecast11.6    Others - China IVD Sales
Forecast 12.    Profiles of Select Private
Clinical Labs and Diagnostic Services
Companies 12.1    Zhejiang Dian Diagnostics
Technology Co., Ltd. 12.2    ADICON Clinical
Laboratories (Privately held) 12.3    Guangzhou
Kingmed Diagnostics Center Co. Ltd. 12.4  
 Kindstar Global (Privately held) 12.5  
 BGI-Shenzhen 12.6    OriGene Technologies

12
Get Free Customization in this Report
Diagnostics Market Reports https//www.renub.
com/diagnostics-14-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com